Brief: Pharmaust Ltd Seeks Trading Halt
25/02/2024 22:37
Feb 26 (Reuters) - Pharmaust Ltd PAA.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON PHASE 1 MND
STUDY
TOP-LINE RESULTS
Source text for Eikon: ID:nASX67NlCq
Further company coverage: PAA.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility